MAROTTA, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 48
EU - Europa 31
AS - Asia 16
AF - Africa 1
Totale 96
Nazione #
US - Stati Uniti d'America 48
IT - Italia 11
DE - Germania 5
SG - Singapore 5
UA - Ucraina 5
CN - Cina 4
PL - Polonia 4
TR - Turchia 4
FI - Finlandia 2
BD - Bangladesh 1
FR - Francia 1
GB - Regno Unito 1
IE - Irlanda 1
IN - India 1
KR - Corea 1
NG - Nigeria 1
RU - Federazione Russa 1
Totale 96
Città #
Woodbridge 10
Ann Arbor 8
Jacksonville 6
Chandler 5
Gdansk 4
Izmir 4
Naples 4
Munich 3
Princeton 3
Ashburn 2
Boardman 2
Milan 2
Abakaliki 1
Andover 1
Dublin 1
Fairfield 1
Helsinki 1
Immenstadt im Allgäu 1
Los Angeles 1
Moscow 1
Nanchang 1
Nanjing 1
Pellezzano 1
Pune 1
Shenyang 1
Singapore 1
Vancouver 1
Yiwu 1
Totale 69
Nome #
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 73
GH provocative tests stimulate the growth in children with idiopathic short stature 6
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 5
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 3
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 3
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 3
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 3
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 2
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 2
Benign thyroid nodules with RAS mutation grow faster 2
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 2
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 2
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 2
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 2
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 2
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 2
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 2
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 2
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 1
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 1
Hepatic arterial embolization in patients with neuroendocrine tumors 1
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 1
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 1
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 1
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 1
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 1
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 1
Radioiodide induces apoptosis in human thyroid tissue in culture 1
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 1
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 1
Limitations of Chromogranin A in clinical practice 1
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 1
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 1
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 1
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 1
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 1
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 1
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 1
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 1
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 1
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 1
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 1
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 1
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 1
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 1
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 1
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 1
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 1
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 1
The evolving field of kinase inhibitors in thyroid cancer 1
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 1
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 1
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 1
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 1
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 1
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 1
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 1
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 1
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 1
Growing thyroid nodules with benign histology and RET rearrangement 1
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 1
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 1
Totale 162
Categoria #
all - tutte 628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 1 1 0 1 0 1 0 1 0 1 0
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/202689 89 0 0 0 0 0 0 0 0 0 0 0
Totale 162